rhApoAI-PBGD

N/A

Report date: 2022/07/01 15:29:28

Base Information

Drug NamerhApoAI-PBGD
Drug Alias NamerhApoAI-PBGD
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionPorphobilinogen deaminase stimulants
TargetsPorphobilinogen deaminase
Therapy Area/IndicationsPorphyria, Acute Intermittent
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Navarra
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Navarra
Inactive CompaniesN/A
Active IndicationsPorphyria, Acute Intermittent
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A